Assessment of oligometastasis status of prostate cancer following combined robot-assisted radical prostatectomy and androgen deprivation versus androgen deprivation therapy alone using PSA percentage decline rate.

Journal: Frontiers in endocrinology
PMID:

Abstract

OBJECTIVE: To compare the tumor control in prostate cancer patients with oligo-metastasis following combined robot-assisted radical prostatectomy and androgen deprivation versus androgen deprivation therapy alone based on total prostate-specific antigen (tPSA) assessment.

Authors

  • Xuwen Li
    College of Life Science and Bioengineering, Beijing University of Technology, Intelligent Physiological Measurement and Clinical Translation, Beijing International Base for Scientific and Technological Cooperation, Beijing, 100024, China.
  • Haibo Xi
    Department of Urology, The First Affiliated Hospital of Nanchang University, Nanchang, China.
  • Xiaofeng Cheng
    Department of Urology, The First Affiliated Hospital of Nanchang University, Nanchang, China.
  • Yue Yu
    Department of Mathematics, Lehigh University, Bethlehem, PA, USA.
  • Cheng Zhang
    College of Forestry, Jiangxi Agricultural University, Nanchang, Jiangxi Province, China.
  • Gongxian Wang
    Department of Urology, The First Affiliated Hospital of Nanchang University, Nanchang, P.R. China.
  • Xiaochen Zhou
    Department of Urology, The First Affiliated Hospital of Nanchang University, Nanchang, P.R. China.